Two Supplemented Against Skin Reactivity

NCT01368224 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
96
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

L'Oreal

Collaborators